FP:ERYP Erytech Pharma S.A.

Erytech Pharma is a France based clinical-stage biopharmaceutical company. It is engaged conducting activities in research and development in the fields of treatment for acute leukemia and other orphan diseases.This company has ADRs that trade in the U.S. as the symbol ERYP.

2.14 EUR
As of 11/29/2021

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  France
Country of incorporation:  France
IPO date:  01/01/1900
Stock exchange:    Euronext Paris
Exchange country:   France
Market cap:   60,309,364 EUR
Current dividend yield:   0.00%
ISIN:        FR0011471135

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy